Improving the Clinical Application of Natural Killer Cells by Modulating Signals Signal from Target Cells

Relapsed acute myeloid leukemia (AML) is a significant post-transplant complication lacking standard treatment and associated with a poor prognosis. Cellular therapy, which is already widely used as a treatment for several hematological malignancies, could be a potential treatment alternative. Natur...

Descripción completa

Detalles Bibliográficos
Autores principales: Holubova, Monika, Leba, Martin, Gmucova, Hana, Caputo, Valentina S., Jindra, Pavel, Lysak, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679089/
https://www.ncbi.nlm.nih.gov/pubmed/31311121
http://dx.doi.org/10.3390/ijms20143472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679089/
https://www.ncbi.nlm.nih.gov/pubmed/31311121
http://dx.doi.org/10.3390/ijms20143472

Ejemplares similares